Report : A-Z HCD items in Formulary 21/12/2024 16:41:58
[
Back
]
Section
Status
CCG
Name
06.06.01
Formulary
Abaloparatide Eladynos
®
13.05.03
Formulary
Abrocitinib Cibinqo
®
11.08.02
Formulary
Aflibercept Eylea
®
04.07.04.02
Formulary
Atogepant Aquipta
®
10.01.03
Formulary
Baricitinib Olumiant
®
11.08.02
Formulary
Bevacizumab 1.25mg/0.5ml intravitreal injection
10.01.03
Formulary
Bimekizumab Bimzelx
®
13.05.03
Formulary
Brodalumab Kyntheum
®
11.08.02
Formulary
Brolucizumab Beovu
®
13.05.03
Formulary
Deucravacitinib Sotyktu
04.07.04.02
Formulary
Eptinezumab Vyepti
®
04.07.04.02
Formulary
Erenumab Aimovig
®
01.05.03
Formulary
Etrasimod Velsipity
®
11.08.02
Formulary
Faricimab Vabysmo
®
01.05.03
Formulary
Filgotinib Jyseleca
®
10.01.03
Formulary
Filgotinib Jyseleca
®
04.07.04.02
Formulary
Fremanezumab Ajovy
®
04.07.04.02
Formulary
Galcanezumab Emgality
®
10.01.03
Formulary
Golimumab Simponi
®
13.05.03
Formulary
Guselkumab Tremfya
®
10.01.03
Formulary
Ixekizumab Taltz
®
13.05.03
Formulary
Lebrikizumab Ebglyss
®
04.04
Formulary
Pitolisant Wakix
®
11.08.02
Formulary
Ranibizumab 10mg/1ml injection Lucentis
®
08.03.04.02
Formulary
Relugolix Orgovyx
®
01.05.03
Formulary
Risankizumab Skyrizi
®
13.05.03
Formulary
Ritlecitinib Litfulo
®
06.06.02
Formulary
Romosozumab Evenity
®
06.05.01
Formulary
Somatrogon Ngenla®
10.01.03
Formulary
Tocilizumab RoActemra
®
10.01.03
Formulary
Tofacitinib Xeljanz
®
13.05.03
Formulary
Tralokinumab Adtralza
®
01.05.03
Formulary
Upadacitinib Rinvoq
®
10.01.03
Formulary
Upadacitinib Rinvoq
®
13.05.03
Formulary
Upadacitinib Rinvoq
®
North East and North Cumbria